SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-108170
Filing Date
2020-04-15
Accepted
2020-04-15 16:49:32
Documents
4
Effectiveness Date
2020-04-15

Document Format Files

Seq Description Document Type Size
1 DEFA14A d903873ddefa14a.htm DEFA14A 18765
2 GRAPHIC g903873d903873d14aimg3.jpg GRAPHIC 1057
3 GRAPHIC g903873d903873d14aimg6.jpg GRAPHIC 1105
4 GRAPHIC g903873d903873d14aimg8.jpg GRAPHIC 11858
  Complete submission text file 0001193125-20-108170.txt   39565
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38485 | Film No.: 20794215
SIC: 2834 Pharmaceutical Preparations